Roth, G.A., G.A. Mensah, C.O. Johnson, G. Addolorato, E. Ammirati, L.M. Baddour, et al. 2020. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology 76: 2982–3021.

Article  PubMed  PubMed Central  Google Scholar 

Rudd, K.E., S.C. Johnson, K.M. Agesa, K.A. Shackelford, D. Tsoi, D.R. Kievlan, et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease study. Lancet 395: 200–211.

Article  PubMed  PubMed Central  Google Scholar 

Townsend, N., D. Kazakiewicz, F. Lucy Wright, A. Timmis, R. Huculeci, A. Torbica, et al. 2022. Epidemiology of cardiovascular disease in Europe Nature Reviews. Cardiology 19: 133–143.

PubMed  Google Scholar 

Tsao, C.W., A.W. Aday, Z.I. Almarzooq, A. Alonso, A.Z. Beaton, M.S. Bittencourt, et al. 2022. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation CIR0000000000001052.

Adamo, L., C. Rocha-Resende, S.D. Prabhu, and D.L. Mann. 2020. Reappraising the role of inflammation in heart failure. Nature Reviews Cardiology.

Levine, B., J. Kalman, L. Mayer, H.M. Fillit, and M. Packer. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. The New England journal of medicine 323: 236–241.

Article  CAS  PubMed  Google Scholar 

Zhang, Y., Z. Huang, and H. Li. 2017. Insights into innate immune signalling in controlling cardiac remodelling. Cardiovascular research 113: 1538–1550.

Article  CAS  PubMed  Google Scholar 

Paulus, W.J., and M.R. Zile. 2021. From systemic inflammation to myocardial fibrosis: The heart failure with preserved ejection fraction paradigm revisited. Circulation research 128: 1451–1467.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frantz, S., I. Falcao-Pires, J.L. Balligand, J. Bauersachs, D. Brutsaert, M. Ciccarelli, et al. 2018. The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. European Journal of Heart Failure 20: 445–459.

Article  PubMed  Google Scholar 

Steffens, S., M. Nahrendorf, and R. Madonna, 2021. Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies. European Heart Journal.

Ridker, P.M., B.M. Everett, T. Thuren, J.G. MacFadyen, W.H. Chang, C. Ballantyne, et al. 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England journal of medicine 377: 1119–1131.

Article  CAS  PubMed  Google Scholar 

Everett, B.M., J.H. Cornel, M. Lainscak, S.D. Anker, A. Abbate, T. Thuren, et al. 2019. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139: 1289–1299.

Article  CAS  PubMed  Google Scholar 

Cao, D., Y. Liu, X. Chen, J. Liu, J. Liu, W. Lai, et al. 2022. Activation of iNKT cells at the maternal-fetal interface predisposes offspring to cardiac injury. Circulation 145: 1032–1035.

Article  CAS  PubMed  Google Scholar 

Chen, X., J. Liu, J. Liu, W.J. Wang, W.J. Lai, S.H. Li, et al. 2020. alpha-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice. Acta pharmacologica Sinica 41: 1416–1426.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aronoff, L., S. Epelman, and X, Clemente-Casares. 2018. Isolation and identification of extravascular immune cells of the heart. Journal of Visualized Experiments.

Dick, S.A., A. Wong, H. Hamidzada, S. Nejat, R. Nechanitzky, S. Vohra, et al. 2022. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Science Immunology 7: eabf7777.

Qu, X., Y. Liu, D. Cao, J. Chen, Z. Liu, H. Ji, et al. 2019. BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways. The Journal of biological chemistry 294: 19877–19888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soliman, H., and F.M.V. Rossi. 2020. Cardiac fibroblast diversity in health and disease. Matrix biology : Journal of the International Society for Matrix Biology 91–92: 75–91.

Article  PubMed  Google Scholar 

Gibb, A.A., M.P. Lazaropoulos, and J.W. Elrod. 2020. Myofibroblasts and fibrosis: Mitochondrial and metabolic control of cellular differentiation. Circulation research 127: 427–447.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frangogiannis, N.G. 2019. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Molecular Aspects of Medicine 65: 70–99.

Article  CAS  PubMed  Google Scholar 

Mann, D.L. 2015. Innate immunity and the failing heart: The cytokine hypothesis revisited. Circulation research 116: 1254–1268.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy, S.P., R. Kakkar, C.P. McCarthy, and J.L. Januzzi Jr. 2020. Inflammation in heart failure: JACC state-of-the-art review. Journal of the American College of Cardiology 75: 1324–1340.

Article  PubMed  Google Scholar 

Altwegg, L.A., M. Neidhart, M. Hersberger, S. Muller, F.R. Eberli, R. Corti, et al. 2007. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: A novel, early, and sensitive marker of acute coronary syndromes. European heart journal 28: 941–948.

Article  CAS  PubMed  Google Scholar 

Buechler, M.B., W. Fu, and S.J. Turley. 2021. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity 54: 903–915.

Article  CAS  PubMed  Google Scholar 

Zhou, X., R.A. Franklin, M. Adler, J.B. Jacox, W. Bailis, J.A. Shyer, et al. 2018. Circuit design features of a stable two-cell system. Cell 172 (744–757): e17.

Google Scholar 

Zhang, Y., J. Bauersachs, and H.F. Langer. 2017. Immune mechanisms in heart failure. European Journal of Heart Failure 19: 1379–1389.

Article  PubMed  Google Scholar 

Mann, D.L., V.K. Topkara, S. Evans, and P.M. Barger, 2010. Innate immunity in the adult mammalian heart: for whom the cell tolls. Transactions of the American Clinical and Climatological Association 121: 34–50; discussion 50–1.

Jarrah, A.A., and S.T. Tarzami. 2015. The duality of chemokines in heart failure. Expert review of clinical immunology 11: 523–536.

Article  CAS  PubMed  Google Scholar 

Zhang, W., K.J. Lavine, S. Epelman, S.A. Evans, C.J. Weinheimer, P.M. Barger, et al. 2015. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. Journal of the American Heart Association 4: e001993.

Article  PubMed  PubMed Central  Google Scholar 

Parrillo, J.E., R.E. Cunnion, S.E. Epstein, M.M. Parker, A.F. Suffredini, M. Brenner, et al. 1989. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. The New England journal of medicine 321: 1061–1068.

Article  CAS  PubMed  Google Scholar 

Martelli, D., S.T. Yao, M.J. McKinley, and R.M. McAllen. 2014. Reflex control of inflammation by sympathetic nerves, not the vagus. Journal of Physiology 592: 1677–1686.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saito, S., Y. Hiroi, Y. Zou, R. Aikawa, H. Toko, F. Shibasaki, et al. 2000. beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. The Journal of biological chemistry 275: 34528–34533.

Article  CAS  PubMed  Google Scholar 

Murray, D.R., S.D. Prabhu, and B. Chandrasekar. 2000. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101: 2338–2341.

Article  CAS  PubMed  Google Scholar 

Mann, D.L. 2002. Inflammatory mediators and the failing heart: Past, present, and the foreseeable future. Circulation research 91: 988–998.

Article  CAS  PubMed  Google Scholar 

Xia, G.L., Y.K. Wang, and Z.Q. Huang. 2016. The correlation of serum myeloid-related protein-8/14 and eosinophil cationic protein in patients with coronary artery disease. BioMed Research International 2016: 4980251.

Article  PubMed  PubMed Central  Google Scholar 

Lech, M., J. Guess, J. Duffner, J. Oyamada, C. Shimizu, S. Hoshino, et al. 2019. Circulating markers of inflammation persist in children and adults with giant aneurysms after Kawasaki disease. Circulation: Genomic and Precision Medicine 12: e002433.

Santilli, F., L. Paloscia, R. Liani, M. Di Nicola, M. Di Marco, S. Lattanzio, et al. 2014. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. Journal of the American Heart Association 3.

Berg, D.D., R.W. Yeh, L. Mauri, D.A. Morrow, D.J. Kereiakes, D.E. Cutlip, et al. 2021. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. Journal of Thrombosis and Thrombolysis 51: 675–681.

Article  PubMed  Google Scholar 

Boyd, J.H., B. Kan, H. Roberts, Y. Wang, and K.R. Walley. 2008. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circulation research 102: 1239–1246.

Article  CAS  PubMed  Google Scholar 

Müller, I., T. Vogl, K. Pappritz, K. Miteva, K. Savvatis, D. Rohde, et al. 2017. Pathogenic role of the damage-associated molecular patterns S100A8 and S100A9 in Coxsackievirus B3-induced myocarditis. Circulation: Heart Failure 10.

Wu, Y., Y. Li, C. Zhang, Y. Wang, W. Cui, et al. 2014. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-induced cardiac inflammation and injury. Hypertension 63: 1241–50.

Marinkovic, G., H. Grauen Larsen, T. Yndigegn, I.A. Szabo, R.G. Mares, L. de Camp, et al. 2019. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. European heart journal 40: 2713–2723.

Article  CAS  PubMed  Google Scholar 

Sreejit, G., A. Abdel-Latif, B. Athmanathan, R. Annabathula, A. Dhyani, S.K. Noothi, et al. 2020. Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction. Circulation 141: 1080–1094.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volz, H.C., D. Laohachewin, C. Seidel, F. Lasitschka, K. Keilbach, A.R. Wienbrandt, et al. 2012. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Research in Cardiology 107: 250.